IODINE (124I) GIRENTUXIMAB Uses, Dosage, Side Effects and more

IODINE (124I) GIRENTUXIMAB is under investigation in clinical trial NCT01762592 (REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT).

Trade Name IODINE (124I) GIRENTUXIMAB
Generic Girentuximab I-124
Girentuximab I-124 Other Names IODINE (124I) GIRENTUXIMAB
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share